☆ 4.0 Letter

Kikuchi disease, macrophage activation syndrome, and systemic juvenile arthritis: a new case associated with a mutation in the perforin gene

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2015)

Journal

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Volume 44, Issue 5, Pages 429-430

Publisher

TAYLOR & FRANCIS LTD

DOI: 10.3109/03009742.2015.1033009

Keywords

-

Categories

Rheumatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Pediatrics

JAK inhibitors in systemic juvenile idiopathic arthritis

Tingyan He, Yu Xia, Ying Luo, Jun Yang

Summary: This study aimed to evaluate the efficacy and potential adverse effects of JAKi in patients with systemic juvenile idiopathic arthritis (SJIA). The results showed that JAKi may be an alternative or adjuvant agent for patients with persistently active disease, glucocorticoid-related adverse reactions, or SJIA-MAS.

FRONTIERS IN PEDIATRICS (2023)

Add to Collection

Article Immunology

The dynamics of laboratory markers reflecting cytokine overproduction in macrophage activation syndrome complicated with systemic juvenile idiopathic arthritis

Shuya Kaneko, Masaki Shimizu, Futaba Miyaoka, Asami Shimbo, Hitoshi Irabu, Mao Mizuta, Yasuo Nakagishi, Naomi Iwata, Junya Fujimura, Masaaki Mori, Tomohiro Morio

Summary: This study validates the correlation between laboratory markers reflecting disease activity of macrophage activation syndrome (MAS) and serum cytokine levels, and identifies valuable laboratory markers that change over time for a prompt MAS diagnosis.

CLINICAL IMMUNOLOGY (2023)

Add to Collection

Article Pediatrics

Kawasaki Disease and Systemic Juvenile Idiopathic Arthritis - Two Ends of the Same Spectrum

Ellen Go, Mira van Veenendaal, Cedric Manlhiot, Rayfel Schneider, Brian W. McCrindle, Rae S. M. Yeung

Summary: This study describes the disease course of a small proportion of patients with both Kawasaki disease and systemic juvenile idiopathic arthritis, characterized by refractory Kawasaki disease, high prevalence of coronary artery dilatation, and shared immunopathology potentially linking the two conditions.

FRONTIERS IN PEDIATRICS (2021)

Add to Collection

Article Multidisciplinary Sciences

Lipopolysaccharide stimulation test on cultured PBMCs assists the discrimination of cryopyrin-associated periodic syndrome from systemic juvenile idiopathic arthritis

Chao-Yi Wu, Wen-Lang Fan, Ying-Ming Chiu, Huang-Yu Yang, Wen- Lee, Jing-Long Huang

Summary: The study found that inflammatory cytokines in plasma and PBMC response levels can help differentiate CAPS and persistent sJIA. In stimulation assays, CAPS PBMCs showed stronger responses to LPS inflammasome stimulation.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Rheumatology

Variation in Treatment of Children Hospitalized With New-Onset Systemic Juvenile Idiopathic Arthritis in the US

Rosemary G. Peterson, Rui Xiao, Karen E. James, Hannah Katcoff, Brian T. Fisher, Pamela F. Weiss

Summary: The study found significant variation in the use of biologics and glucocorticoids in children hospitalized with new-onset systemic JIA, with noticeable differences between hospitals. Despite increasing evidence supporting the use of biologics for improved outcomes, many children did not receive biologic treatment and a high rate of glucocorticoid exposure persisted.

ARTHRITIS CARE & RESEARCH (2021)

Add to Collection

Review Rheumatology

Treatment of systemic juvenile idiopathic arthritis

Claas H. Hinze, Dirk Foell, Christoph Kessel

Summary: Systemic juvenile idiopathic arthritis (sJIA) is a disease characterized by severe systemic inflammation and arthritis. It poses challenges to rheumatologists treating pediatric and adult patients worldwide. Although treatment plans exist for classic sJIA, there is still a lack of clear treatment approaches for early sJIA without arthritis and complicated sJIA.

NATURE REVIEWS RHEUMATOLOGY (2023)

Add to Collection

Review Rheumatology

Therapeutic plasma exchange in refractory macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a case-based review

Eduardo Liquidano-Perez, Gibert Maza-Ramos, Jose Luis Salazar-Bailon, Marco Antonio Yamazaki-Nakashimada, Francisco Rivas-Larrauri

Summary: This study presents a refractory case of soJIA complicated with MAS successfully treated with plasma exchange, resulting in significant improvement.

RHEUMATOLOGY INTERNATIONAL (2022)

Add to Collection

Article Rheumatology

Treatment for macrophage activation syndrome associated with systemic juvenile idiopathic arthritis in Japan

Masaki Shimizu, Kenichi Nishimura, Naomi Iwata, Takahiro Yasumi, Hiroaki Umebayashi, Yasuo Nakagishi, Yuka Okura, Nami Okamoto, Noriko Kinjo, Mao Mizuta, Masato Yashiro, Junko Yasumura, Hiroyuki Wakiguchi, Tomohiro Kubota, Mariko Mouri, Utako Kaneko, Masaaki Mori

Summary: A multicenter, retrospective study in Japan revealed that the first-line treatment for MAS in pediatric rheumatology institutes is methylprednisolone pulse therapy and/or cyclosporine A. Dexamethasone palmitate (DEX-P) can be considered as an effective and safe therapeutic option for patients with corticosteroid-resistant MAS.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2023)

Add to Collection

Article Pediatrics

Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis

Mikhail M. Kostik, Eugenia A. Isupova, Konstantin Belozerov, Tatyana S. Likhacheva, Evgeny N. Suspitsin, Rinat Raupov, Vera V. Masalova, Irina A. Chikova, Margarita F. Dubko, Olga V. Kalashnikova, Vyacheslav G. Chasnyk, Randy Q. Cron

Summary: This study provides evidence for the efficacy and safety of short-term increased doses (2-3 times normal) of canakinumab in treating MAS associated with sJIA. Further research on the efficacy and safety of increased doses of canakinumab for the treatment of MAS in children with sJIA is warranted.

FRONTIERS IN PEDIATRICS (2022)

Add to Collection

Article Rheumatology

Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities

R. Naveen, Avinash Jain, Hafis Muhammed, Latika Gupta, Durga P. Misra, Able Lawrence, Vikas Agarwal, Ramnath Misra, Amita Aggarwal

Summary: This study compared the clinical and laboratory parameters of MAS in SLE and sJIA, finding that the two diseases are more similar than dissimilar in clinical features and outcome. The criteria meant for MAS in sJIA or SLE-MAS performed equally well in diagnosing both diseases.

RHEUMATOLOGY INTERNATIONAL (2021)

Add to Collection

Review Rheumatology

Interfering with interferons: targeting the JAK-STAT pathway in complications of systemic juvenile idiopathic arthritis (SJIA)

Emely L. Verweyen, Grant S. Schulert

Summary: Systemic JIA (SJIA) is characterized by severe complications, including macrophage activation syndrome (SJIA-MAS) and lung disease (SJIA-LD), which are driven by interferons (IFNs) and involve the JAK-STAT signaling pathway. New therapeutic advances, such as JAK inhibitors and antibodies targeting IFNs, are urgently needed to address the divergent disease pathogenesis observed in SJIA.

RHEUMATOLOGY (2022)

Add to Collection

Review Medicine, General & Internal

The Role of Interleukin 18/Interleukin 18-Binding Protein in Adult-Onset Still's Disease and Systemic Juvenile Idiopathic Arthritis

Charlotte Girard-Guyonvarc'h, Mathilde Harel, Cem Gabay

Summary: This review summarizes the role and importance of IL-18 and IL-18BP in AOSD and sJIA. It is found that the imbalance of IL-18/IL-18BP is associated with the occurrence of these diseases, and treatment with recombinant IL-18BP shows potential therapeutic effects.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Pediatrics

Diagnosis and Management of the Systemic Juvenile Idiopathic Arthritis Patient with Emerging Lung Disease

Christopher Towe, Alexei A. Grom, Grant S. Schulert

Summary: Chronic lung disease in children with systemic juvenile idiopathic arthritis (SJIA-LD) is a potentially life-threatening complication. The optimal approaches to diagnosis and management of SJIA-LD are still unclear. This review discusses the current clinical understanding of SJIA-LD, including its potential pathogenesis and treatment options, and highlights the urgent unmet needs in this area.

PEDIATRIC DRUGS (2023)

Add to Collection

Article Public, Environmental & Occupational Health

Macrophage Activation Syndrome secondary to Systemic Juvenile Arthritis: A Case

Rishikesh Kafle, Anwesh Bhatta, Sumit Gami, Abhin Sapkota, Dipesh Sharma, Arabindra Yadav, Vijaya Kumar Chikanbanjar

Summary: Macrophage activation syndrome is a rare but life-threatening condition commonly associated with Systemic Juvenile Idiopathic Arthritis, with clinical symptoms being non-specific and often leading to delayed diagnosis. Early recognition and prompt treatment are crucial.

JOURNAL OF NEPAL MEDICAL ASSOCIATION (2021)

Add to Collection

Article Rheumatology

Effective therapy of tocilizumab on systemic juvenile idiopathic arthritis-associated refractory macrophage activation syndrome

Jianqiang Wu, Li Sun, Xuemei Tang, Qi Zheng, Li Guo, Li Xu, Yandie Li, Meiping Lu

Summary: This study retrospectively analyzed clinical data of 14 patients with sJIA-rMAS who failed conventional therapies and were treated with TCZ. The results showed that TCZ could safely and effectively improve the clinical symptoms and laboratory indicators of sJIA-rMAS, with no disease relapse or fatality recorded.

MODERN RHEUMATOLOGY (2022)

Add to Collection

Article Hematology

Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in Italy

Chiara Messina, Marco Zecca, Franca Fagioli, Attilio Rovelli, Stefano Giardino, Pietro Merli, Fulvio Porta, Maurizio Ario, Elena Sieni, Giuseppe Basso, Mimmo Ripaldi, Claudio Favre, Marta Pillon, Antonio Marzollo, Marco Rabusin, Simone Cesaro, Mattia Algeri, Maurizio Caniglia, Paolo Di Bartolomeo, Ottavio Ziino, Francesco Saglio, Arcangelo Prete, Franco Locatelli

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)

Add to Collection

Article Allergy

Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte Society

Stephan Ehl, Itziar Astigarraga, Tatiana von Bahr Greenwood, Melissa Hines, AnnaCarin Horne, Eiichi Ishii, Gritta Janka, Michael B. Jordan, Paul La Rosee, Kai Lehmberg, Rafal Machowicz, Kim E. Nichols, Elena Sieni, Zhao Wang, Jan-Inge Henter

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)

Add to Collection

Article Oncology

A Multicenter Study of Patients with Multisystem Langerhans Cell Histiocytosis Who Develop Secondary Hemophagocytic Lymphohistiocytosis

Deepak Chellapandian, Melissa R. Hines, Rui Zhang, Michael Jeng, Cor van den Bos, Vicente Santa-Maria Lopez, Kai Lehmberg, Elena Sieni, Yini Wang, Taizo Nakano, James A. Williams, Nicholas J. Fustino, Itziar Astigarraga, Ira J. Dunkel, Oussama Abla, Astrid G. S. van Halteren, Deqing Pei, Cheng Cheng, Sheila Weitzman, Lillian Sung, Kim E. Nichols

CANCER (2019)

Add to Collection

Article Oncology

Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study

Jean Donadieu, Islam Amine Larabi, Mathilde Tardieu, Johannes Visser, Caroline Hutter, Elena Sieni, Nabil Kabbara, Mohamed Barkaoui, Jean Miron, Francois Chalard, Paul Milne, Julien Haroche, Fleur Cohen, Zofia Helias-Rodzewicz, Nicolas Simon, Mathilde Jehanne, Alexandra Kolenova, Anne Pagnier, Nathalie Aladjidi, Pascale Schneider, Genevieve Plat, Anne Lutun, Anne Sonntagbauer, Thomas Lehrnbecher, Alina Ferster, Viktoria Efremova, Martina Ahlmann, Laurence Blanc, James Nicholson, Anne Lambilliote, Houda Boudiaf, Andrej Lissat, Karel Svojgr, Fanette Bernard, Sarah Elitzur, Michal Golan, Dmitriy Evseev, Michael Maschan, Ahmed Idbaih, Olga Slater, Milen Minkov, Valerie Taly, Matthew Collin, Jean-Claude Alvarez, Jean-Francois Emile, Sebastien Heritier

JOURNAL OF CLINICAL ONCOLOGY (2019)

Add to Collection

Editorial Material Anesthesiology

Let's measure ferritin in the ICU!

Stefano Skurzak, Elena Sieni

MINERVA ANESTESIOLOGICA (2019)

Add to Collection

Article Hematology

Long-term follow-up of mTOR inhibition for Erdheim-Chester disease

Francesco Pegoraro, Valerio Maniscalco, Francesco Peyronel, Pieter J. Westenend, Tadek R. Hendriksz, Rosa M. Roperto, Alessandro A. Palumbo, Elena Sieni, Paola Romagnani, Eric F. H. van Bommel, Augusto Vaglio

BLOOD (2020)

Add to Collection

Letter Hematology

Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression

Elena Sieni, Francesco Pegoraro, Tommaso Casini, Annalisa Tondo, Barbara Bortone, Maria Moriondo, Chiara Azzari, Luisa Galli, Claudio Favre

BRITISH JOURNAL OF HAEMATOLOGY (2020)

Add to Collection

Article Hematology

Stem cell transplantation for children with hemophagocytic lymphohistiocytosis: results from the HLH-2004 study

Elisabet Bergsten, AnnaCarin Horne, Ida Hed Myrberg, Maurizio Arico, Itziar Astigarraga, Eiichi Ishii, Gritta Janka, Stephan Ladisch, Kai Lehmberg, Kenneth L. McClain, Milen Minkov, Vasanta Nanduri, Diego A. Rosso, Elena Sieni, Jacek Winiarski, Jan-Inge Henter

BLOOD ADVANCES (2020)

Add to Collection

Meeting Abstract Oncology

FLOW CYTOMETRIC PERFORIN AND CD107A SCREENING FOR THE DIAGNOSIS OF FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: REPORT FROM THE ITALIAN REGISTRY

Maria Luisa Coniglio, Martina Da Ros, Daniela Balasco, Virginia Brizzi, Fabiola Dell'Acqua, Carmela De Fusco, Alessandra Todesco, Fabio Timeus, Concetta Micalizzi, Claudio Favre, Elena Sieni

PEDIATRIC BLOOD & CANCER (2020)

Add to Collection

Meeting Abstract Oncology

HEMOPHAGOCYTIC SYNDROME (HLH) AND PRIMARY IMMUNODEFICIENCIES (PIDs): REPORT FROM THE HLH ITALIAN REGISTRY

Maria Luisa Coniglio, Daniela Balasco, Fabiola Dell'Acqua, Concetta Micalizzi, Alessandra Todesco, Nino Trizzino, Eleonora Gambineri, Claudio Favre, Elena Sieni

PEDIATRIC BLOOD & CANCER (2019)

Add to Collection

Meeting Abstract Oncology

VEMURAFENIB IN CHILDREN WITH REFRACTORY LCH: 53 PATIENTS TREATED IN EU AND LEBANON

Jean Donadieu, Islam Amine Larabi, Mathilde Tardieu, Johannes Visser, Hutter Caroline, Elena Sieni, Nabil Kabbara, Mohamed Barkaoui, Paul Milne, Julien Haroche, Zofia Helias, Mathilde Jehanne, Alexandra Kolenova, Anne Pagnier, Nathalie Aladjidi, Aude Marie-Cardine, Genevieve Plat, Anne Lutun, Anne Heisig, Thomas Lehrnbecher, Alina Ferster, Viktoria Efremova, Martina Ahlmann, Laurence Blanc, James Nicholson, Anne Lambilliote, Andrej Lissat, Karel Svojgr, Fanette Bernard, Dmitriy Evseev, Michael Maschan, Ahmed Idbaih, Olga Slater, Milen Minkow, Valerie Taly, Matthew Collin, Jean-Claude Alvarez, Jean-Francois Emile, Sebastien Heritier

PEDIATRIC BLOOD & CANCER (2019)

Add to Collection

Meeting Abstract Oncology

WHOLE BODY MAGNETIC RESONANCE IMAGING (MRI) FOR STAGING LANGERHANS CELL HISTIOCYTOSIS (LCH): A PROSPECTIVE SURVEY AT THE ITALIAN REFERRAL CENTRE

Coniglio Maria Luisa, Elena Sieni, Irene Trambusti, Anna Perrone, Claudio Defilippi, Claudio Favre

PEDIATRIC BLOOD & CANCER (2019)

Add to Collection

Meeting Abstract Oncology

CUTANEOUS ADVERSE EVENTS IN CHILDREN TREATED WITH BRAF-INHIBITOR VEMURAFENIB FOR REFRACTORY BRAF (V600E) MUTATED LANGERHANS CELL HISTIOCYTOSIS: A EUROPEAN COHORT STUDY

Mathilde Tardieu, Amelie Neron, Sophie Duvert-Lehembre, Islam Amine Larabi, Johannes Visser, Hutter Caroline, Elena Sieni, Nabil Kabbara, Mohamed Barkaoui, Paul Milne, Julien Haroche, Zofia Helias-Rodzewicz, Mathilde Jehanne, Sasa Kolenova, Anne Pagnier, Isabelle Templier, Marie Therese-Leccia, Nathalie Aladjidi, Aude Marie-Cardine, Genevieve Plat, Anne Lutun, Anne Heisig, Alina Ferster, Viktoria Efremova, M. Ahlmann, Laurence Blanc, James Nicholson, Anne Lambilliote, Andrej Lissat, Karel Svojgr, Fanette Bernard, Dmitriy Evseev, Michael Maschan, Ahmed Idbaih, Olga Slater, Milen Minkov, Valerie Taly, Matthew Collin, Jean-Claude Alvarez, Jean-Francois Emile, Sebastien Heritier, Jean Donadieu

PEDIATRIC BLOOD & CANCER (2019)

Add to Collection

Meeting Abstract Biophysics

Outcomes of children with hemophagocytic lymphohistiocytosis given allogeneic hematopoietic stem cell transplantation in Italy

P. Merli, M. Zecca, F. Fagioli, A. Rovelli, E. Lanino, A. Bertaina, F. Porta, M. Arico, E. Sieni, G. Basso, M. Ripaldi, C. Favre, M. Pillon, A. Marzollo, M. Rabusin, S. Cesaro, M. Caniglia, P. Di Bartolomeo, O. Ziino, F. Saglio, A. Prete, F. Locatelli, C. Messina

BONE MARROW TRANSPLANTATION (2017)

Add to Collection

Meeting Abstract Medicine, Research & Experimental

Hemophagocytic lymphohistiocytosis in pediatric patients: A single centre experience

Fabio Timeus, Elena Barisone, Elena Vassallo, Ilaria Bini, Sebastian Dorin Asafiei, Francesca Sismondi, Elena Sieni, Franca Fagioli

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.